![Boronate, trifluoroborate, sulfone, sulfinate and sulfonate congeners of oseltamivir carboxylic acid: Synthesis and anti-influenza activity - ScienceDirect Boronate, trifluoroborate, sulfone, sulfinate and sulfonate congeners of oseltamivir carboxylic acid: Synthesis and anti-influenza activity - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S022352341831064X-sc2.jpg)
Boronate, trifluoroborate, sulfone, sulfinate and sulfonate congeners of oseltamivir carboxylic acid: Synthesis and anti-influenza activity - ScienceDirect
Avian Influenza Symptom Monitoring Log Name: Date of initial exposure: ____/____/______ County of Res
![Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary | Antimicrobial Agents and Chemotherapy Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.00422-11/asset/c8e3249f-dfaa-4e1a-b50d-9bcc058d2179/assets/graphic/zac9991003840003.jpeg)
Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary | Antimicrobial Agents and Chemotherapy
![Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary | Antimicrobial Agents and Chemotherapy Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.00422-11/asset/31a8f026-02d8-46be-ae49-578f33c19451/assets/graphic/zac9991003840002.jpeg)
Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary | Antimicrobial Agents and Chemotherapy
![Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary | Antimicrobial Agents and Chemotherapy Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.00422-11/asset/fdfc7d3b-f2f0-4f92-812e-d05d384e235e/assets/graphic/zac9991003840001.jpeg)
Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not Necessary | Antimicrobial Agents and Chemotherapy
![Frontiers | Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy Frontiers | Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy](https://www.frontiersin.org/files/Articles/522496/fphar-11-00786-HTML/image_m/fphar-11-00786-t001.jpg)
Frontiers | Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy
![Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial | SpringerLink Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40261-021-01057-y/MediaObjects/40261_2021_1057_Fig1_HTML.png)